Acclinate Achieves a Coveted Spot on Inc. 5000 Fastest-Growing Companies List

Acclinate Recognized Among America's Fastest-Growing Companies

Acclinate, a company that focuses on health equity and harnesses community-driven engagement for more inclusive clinical trial enrollment, has proudly announced its spot on the prestigious Inc. 5000 list. This annual ranking highlights the fastest-growing private firms in the United States, revealing not only the financial success of these businesses but also their impact on broader societal issues.

A Consistent High Achiever

This recognition marks the second year in a row that Acclinate has been showcased on this influential list. In 2025, Acclinate achieved a commendable ranking of No. 3 in Birmingham, No. 6 in Alabama, and No. 9 within the healthcare sector nationally. These rankings reflect not just the company’s growth, but also its commitment to promoting equitable clinical research practices, a necessity in today’s diverse society.

As Del Smith, Co-Founder and CEO of Acclinate, noted, "This recognition is genuinely a testament to our customers. They trust in our products and the solutions we offer, and they have continuously supported us, which has been vital for our growth. Enjoying that kind of trust, along with the backing of our dedicated team, investors, and community, has made this achievement a reality."

Collaborative Growth

Tiffany Whitlow, Co-Founder and Chief Development Officer, echoed similar sentiments, emphasizing the role of partnerships in their progress. She stated, "From day one, our growth has been driven by collaboration. Our anchor partners, like Innovate Alabama, believed in our vision, helping us to showcase how community-driven engagement can transform clinical research. This recognition by Inc. is not just a win for Acclinate but a celebration of our communities and partners who continue joining us in our pursuit of health equity."

The company has leveraged its NOWINCLUDED community and technological advancements like the e-DICT platform to help sponsors and Clinical Research Organizations (CROs) engage diverse communities. This approach has mobilized participation and led to producing more just research outcomes, a critical factor in today’s clinical Research & Development landscape.

Demand for Community-Centered Approaches

The ongoing rise of Acclinate highlights a growing demand for diversity-focused strategies in inclusive clinical trials. As the world continues to grapple with disparities in healthcare, companies like Acclinate are crucial for ensuring that clinical trials represent diverse populations. This is vital not only for the integrity of research but also for improving health outcomes across various communities.

To explore the entire Inc. 5000 list and delve deeper into the company profiles, the full results can be accessed at www.inc.com/inc5000.

About Acclinate

Acclinate is dedicated to bridging the gap in clinical research participation among varied communities. By employing culturally relevant engagement strategies and cutting-edge technology, the company empowers individuals to take charge of their health while ensuring that clinical trials authentically reflect the demographics they intend to serve.

For media inquiries, contact:

- Lauren Clements, Head of Marketing
- Email: [email protected]
- Phone: 256-435-2800